Impact BioMedical (IBO) Balance Sheet: Assets & Liabilities

Impact BioMedical (IBO) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Impact BioMedical reported total assets of $17.41M and total liabilities of $1.85M. Shareholders' equity was $15.55M, up 265.2% from $4.26M a year earlier. Total debt stood at $0.00 against $3.00K in cash and short-term investments, a net cash position of $3.00K. That puts debt-to-equity at 0.00, compared with 2.08 a year earlier.

Impact BioMedical Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Impact BioMedical Inc. (IBO) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Mar 2019
Current Assets
Cash and Cash Equivalents	0.00	2.00	0.00	0.00	0.05	0.07	0.20
Cash & Short-Term Investments	0.00	2.00	0.00	0.00	0.05	0.07	0.20
Accounts Receivable	0.01	0.18	0.33	0.02	0.20	0.00	0.00
Inventory	0.06	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.34	0.45	0.20	0.12	0.00	0.04	0.00
Total Current Assets	0.41	2.45	0.33	0.12	0.29	0.11	0.22
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.02	0.29	0.28	0.78	0.00	0.00
Long-Term Investments	0.00	0.00	0.00	0.78	4.82	0.63	0.00
Goodwill	0.00	0.00	25.09	25.09	25.09	25.09	0.00
Intangible Assets	16.99	17.81	18.92	20.03	21.15	22.26	0.00
Other Non-Current Assets	0.00	0.02	0.00	0.19	4.82	0.00	0.00
Total Non-Current Assets	16.99	17.84	44.30	46.38	56.14	47.99	0.00
Total Assets	17.41	20.29	44.63	46.50	56.43	48.09	0.22
Current Liabilities
Accounts Payable	0.97	0.31	0.83	0.54	0.12	0.01	0.00
Short-Term Debt	0.00	8.88	12.07	9.99	12.52	1.06	0.00
Current Portion of Long-Term Debt	-	0.04	-	-	-	-	-
Accrued Liabilities	0.19	0.19	0.23	0.06	0.01	0.00	-
Other Current Liabilities	0.82	0.59	0.23	0.06	0.01	0.00	0.00
Total Current Liabilities	1.16	9.79	13.14	10.59	12.65	1.07	0.02
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liabilities	0.69	3.27	3.24	3.24	3.86	5.25	0.00
Other Non-Current Liabilities	0.69	3.27	3.24	3.24	3.86	0.00	0.00
Total Non-Current Liabilities	0.69	3.27	3.24	3.24	3.86	5.25	0.00
Total Liabilities	1.85	13.05	16.37	13.83	16.50	6.32	0.02
Stockholders' Equity
Common Stock	0.11	0.01	0.01	0.07	0.13	0.13	0.60
Retained Earnings	-49.51	-37.67	-12.96	-8.63	-1.57	-0.27	-0.51
Additional Paid-in Capital	62.01	41.86	38.11	38.11	38.06	0.13	0.11
Minority Interest	2.95	2.98	3.04	3.11	3.32	3.86	0.00
Shares Outstanding	104.62	11.50	11.50	11.50	11.50	-	-
Total Stockholders' Equity	15.56	4.26	28.26	32.67	36.61	37.91	0.20
Total Liabilities & Equity	17.41	20.29	44.63	46.50	56.43	0.07	0.22

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Impact BioMedical Balance Sheet

How much debt does Impact BioMedical have?

Impact BioMedical had total debt of $0.00 as of Dec 31, 2025, against $3.00K in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $8.88M a year earlier.

What are Impact BioMedical's total assets?

Impact BioMedical reported total assets of $17.41M as of Dec 31, 2025, down 14.2% from $20.29M a year earlier. Total liabilities were $1.85M.

What is Impact BioMedical's shareholders' equity?

Impact BioMedical's shareholders' equity was $15.55M as of Dec 31, 2025, or about $0.15 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition